Swiss National Bank’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
63,533
+8,000
| +14% | +$324K | ﹤0.01% | 1643 |
|
|
2025
Q1 | $2.85M | Buy |
55,533
+3,200
| +6% | +$164K | ﹤0.01% | 1569 |
|
|
2024
Q4 | $2.9M | Buy |
52,333
+600
| +1% | +$33.2K | ﹤0.01% | 1647 |
|
|
2024
Q3 | $1.7M | Buy |
51,733
+4,400
| +9% | +$145K | ﹤0.01% | 1957 |
|
|
2024
Q2 | $1.29M | Buy |
47,333
+4,900
| +12% | +$133K | ﹤0.01% | 2044 |
|
|
2024
Q1 | $1.54M | Buy |
42,433
+600
| +1% | +$21.8K | ﹤0.01% | 1980 |
|
|
2023
Q4 | $847K | Sell |
41,833
-7,600
| -15% | -$154K | ﹤0.01% | 2330 |
|
|
2023
Q3 | $878K | Buy |
49,433
+14,500
| +42% | +$258K | ﹤0.01% | 2311 |
|
|
2023
Q2 | $631K | Sell |
34,933
-2,500
| -7% | -$45.2K | ﹤0.01% | 2494 |
|
|
2023
Q1 | $471K | Sell |
37,433
-4,400
| -11% | -$55.3K | ﹤0.01% | 2541 |
|
|
2022
Q4 | $613K | Buy |
+41,833
| New | +$613K | ﹤0.01% | 2526 |
|